Jan Paul de Boer
Overview
Explore the profile of Jan Paul de Boer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
2185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Ykema B, Rigter L, Spaander M, Moons L, Bisseling T, Aleman B, et al.
Dig Endosc
. 2021 Apr;
34(1):163-170.
PMID: 33928678
Background: Hodgkin's lymphoma (HL) survivors treated with abdominal radiotherapy and/or procarbazine have an increased risk of developing colorectal neoplasia. Aims: We evaluated the clinicopathological characteristics and risk factors for developing...
22.
Duinkerken C, de Weger V, Dreschler W, van der Molen L, Pluim D, Rosing H, et al.
Otol Neurotol
. 2021 Mar;
42(5):678-685.
PMID: 33710154
Objectives: To determine safety, feasibility, and preliminary activity of transtympanic injection of sodium thiosulfate (STS) against cisplatin-induced hearing loss (CIHL).DESIGN Randomized controlled trial.SETTING Tertiary cancer hospital.PATIENTS Adults to be treated...
23.
de Vries S, Schaapveld M, Janus C, Daniels L, Petersen E, van der Maazen R, et al.
J Natl Cancer Inst
. 2020 Dec;
113(6):760-769.
PMID: 33351090
Background: Few studies have examined the impact of treatment-related morbidity on long-term, cause-specific mortality in Hodgkin lymphoma (HL) patients. Methods: This multicenter cohort included 4919 HL patients, treated before age...
24.
Los-de Vries G, de Boer M, van Dijk E, Stathi P, Hijmering N, Roemer M, et al.
Blood
. 2020 Dec;
136(25):2927-2932.
PMID: 33331925
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a very rare type of T-cell lymphoma that is uniquely caused by a single environmental stimulus. Here, we present a comprehensive genetic...
25.
Piek M, Postma E, van Leeuwaarde R, de Boer J, Bos A, Lok C, et al.
Thyroid
. 2020 Oct;
31(4):658-668.
PMID: 33012254
Thyroid cancer is one of the most common carcinomas diagnosed in adolescents and young adults, with a rapidly rising incidence for the past three decades. Surgery is the standard treatment...
26.
Cioni B, Zaalberg A, van Beijnum J, Melis M, van Burgsteden J, Muraro M, et al.
Nat Commun
. 2020 Sep;
11(1):4498.
PMID: 32908142
The androgen receptor (AR) is the master regulator of prostate cancer (PCa) development, and inhibition of AR signalling is the most effective PCa treatment. AR is expressed in PCa cells...
27.
de Boer M, Hauptmann M, Hijmering N, van Noesel C, Rakhorst H, Meijers-Heijboer H, et al.
Blood
. 2020 May;
136(11):1368-1372.
PMID: 32452517
No abstract available.
28.
Ykema B, Rigter L, Spaander M, Moons L, Bisseling T, Aleman B, et al.
J Clin Med
. 2020 Jan;
9(1).
PMID: 31936745
Background: Hodgkin lymphoma (HL) survivors have an increased colorectal cancer (CRC) risk. Diagnostic accuracy of quantitative fecal immunochemical testing (FIT, OC Sensor) and/or a multi-target stool DNA test (mt-sDNA, Cologuard)...
29.
Elbers J, Al-Mamgani A, Tesseslaar M, van den Brekel M, Lange C, van der Wal J, et al.
Radiother Oncol
. 2019 Sep;
142:79-84.
PMID: 31563412
Background And Purpose: Radiotherapy (RT) with cetuximab is an alternative for advanced-stage head and neck squamous cell carcinoma (HNSCC) patients who are unfit for cisplatin treatment. As 5-year overall survival...
30.
de Boer M, van Middelkoop M, Hauptmann M, van der Bijl N, Bosmans J, Hendriks-Brouwer N, et al.
Aesthet Surg J
. 2019 Jun;
40(2):156-164.
PMID: 31242279
Background: Breast implant-related health problems are a subject of fierce debate. Reliable population-based estimates of implant prevalence rates are not available, however, due to a lack of historical registries and...